tradingkey.logo
tradingkey.logo
Search

RenovoRx Inc

RNXT
Add to Watchlist
1.040USD
-0.120-10.34%
Close 11-13 16:00(ET)
46.94MMarket Cap
LossP/E TTM

RenovoRx Inc (RNXT) Stock Price Target & Forecast

Analyst Rating

Based on 4 analysts giving stock ratings to RenovoRx Inc in the past month.

Buy
0 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
7.125USD+435.71%

RNXT Analyst Recommendation Trends

In the current month, RNXT has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RNXT average Analyst price target in the last month is 7.125.

2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
Strong Buy
0
0
0
0
0
0
0
0
Buy
4
4
4
4
4
4
4
4
Hold
0
0
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
4
4
4
4
4
4
4
4

RNXT Analyst Rating for Peer Comparison

Updated: Nov 5, 2026
Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Ratings
Analysts
Stryker Corp
SYK
10
14
6
0
0
30
Dexcom Inc
DXCM
13
12
4
0
0
29
Medtronic PLC
MDT
8
11
10
0
0
29
Abbott Laboratories
ABT
11
13
4
0
0
28
Guardant Health Inc
GH
12
14
2
0
0
28
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
5
20
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
12
4
0
0
21

Financial Forecasting

Based on analysts' estimates, RNXT EPS is projected to reach -0.058 in FY2026Q4, following reported EPS of -0.076 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.

EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.08
-0.07
-0.06
-0.06
-0.06
Actual
-0.09
-0.06
-0.08
--
--
Surprise
-15.72%
+15.10%
-26.12%
--
--

FAQs

What is RenovoRx Inc's expected revenue for the next quarter?

RenovoRx Inc's expected revenue is 1.34M.

What is RenovoRx Inc's price target?

Analysts forecast that RenovoRx Inc's price target is USD 7.12, with the highest forecast at USD 14.50 and the lowest forecast at USD 3.00.

How have RenovoRx IncRNXT's recent earnings per share performed?

The market expectation was USD -0.08, while RenovoRx IncRNXT's earnings per share (EPS) for the previous quarter was USD -0.06. EPS for the next quarter is expected at USD -0.06.

What is the analyst rating for RenovoRx Inc?

Based on the ratings of RenovoRx Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.